http://www.mmm-online.com/rare-diseases/topic/16317/ Articles tagged with Rare Diseases from Medical Marketing and Media MMM mmmsubs@haymarketmedia.com no Aegerion's Juxtapid is first to market for treating the ultrarare inherited cholesterol condition HoFH, or homozygous familial hypercholesterolemia. http://www.mmm-online.com/drug-for-ultrarare-lipid-disorder-okd-by-fda/article/273972/ Wed, 26 Dec 2012 20:12:38 GMT Aegerion's Juxtapid is first to market for treating the ultrarare inherited cholesterol condition HoFH, or homozygous familial hypercholesterolemia. MMM Smartphones will influence 19% of in-store sales in four years, Janssen acquires an experimental heart treatment, and the FDA can now fast-track rare disease medications. http://www.mmm-online.com/company-news-smartphones-janssen-fda/article/247907/ Thu, 28 Jun 2012 17:13:39 GMT Smartphones will influence 19% of in-store sales in four years, Janssen acquires an experimental heart treatment, and the FDA can now fast-track rare disease medications. MMM Corcept Therapeutics said its Cushing's syndrome drug will be launched three weeks earlier than expected. http://www.mmm-online.com/company-news-corcept-therapeutics-and-daiichi-sankyo/article/233371/ Fri, 23 Mar 2012 14:35:58 GMT Corcept Therapeutics said its Cushing's syndrome drug will be launched three weeks earlier than expected. MMM Shire has pulled its drug, Replagal, from FDA review. The company was set to go before the agency next month, but preliminary talks indicated the FDA was going to require more testing. http://www.mmm-online.com/shire-exits-fabrys-market-citing-costs-as-fda-weighs-more-research/article/232195/ Thu, 15 Mar 2012 18:56:02 GMT Shire has pulled its drug, Replagal, from FDA review. The company was set to go before the agency next month, but preliminary talks indicated the FDA was going to require more testing. MMM